Weight gain effectivity of balamoola with vidarikand in atikrusha.

Not yet recruiting

• Conditions: Atikrusha

• Registration Number: CTRI/2019/05/019076
• Lead Sponsor: PDEAs collage of ayurved and research centre

Brief Summary

*Vidarikand* and *Bala* are described in *brimhaneeyamaha kshaya* in *charak samhita*. Ithas properties of *brimhan karma*.Leanness is the condition of being excessively *krusha. Charakacharya* described ati*krush* as the person has wasting up buttocks, abdomen and neck,prominent vascular network, thin skin and bone and thick nodes. Maintaining aweight below ones ideal weight range possess a number of risks. Including  increased risk for infection anaemia , osteoporosisand other conditions.

*Brimhaniya maha kashya* is a group of herbs which is supposed to be having influence onmetabolic functions. Probable mode of action of *brimhan* have predominance of *guru,snigdha,sheeta* and *mand guna ,madhurrasa, madhur vipak* causing *brimhan*effect

Theconditions or disease in which the body of person become emaciated, having lessquantity of *Rasdhatu* further causinga status of *mauns hinata* or *mauns kshayam*. According to *acharya charaka* intake of food in lessquantity is prime factor producing leanness and weight loss *maunskshayam* or weight loss means personhaving *krushata* or thin bodypersonality it means in this condition *brimhan*has been advocated in the classic for this management.

oporosisand other conditions.*Brimhaniya maha kashya* is a group of herbs which is supposed to be having influence onmetabolic functions. Probable mode of action of *brimhan* have predominance of *guru,snigdha,sheeta* and *mand guna ,madhurrasa, madhur vipak* causing *brimhan*effect

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-07
• Last Update Posted: 2019-10-05

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

subjects having BMI below 18.5 and symptoms of atikrusha.

Exclusion Criteria

known case of HIV,Tuberculosis,Hyperthyroidism, Malignancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TO OBSERVE EFFICACY OF BOTH THE DRUGS in subjects having bmi below 18.5.	TO OBSERVE EFFICACY OF BOTH THE DRUGS in subjects having bmi below 18.5. | to compare brimhaneeya effect of vidarikand and balamoola churna in atikrusha for 3 months with every month follow up.
to compare brimhaneeya effect of vidarikand and balamoola churna in atikrusha for 3 months with every month follow up.	TO OBSERVE EFFICACY OF BOTH THE DRUGS in subjects having bmi below 18.5. | to compare brimhaneeya effect of vidarikand and balamoola churna in atikrusha for 3 months with every month follow up.

Secondary Outcome Measures

Name	Time	Method
1. to observe adverse effect if any.	2. to study brimhaneeya of vidarikand and balamoola.

Trial Locations

Locations (1)

PDEAs collage of ayurved and research centre; 🇮🇳 Pune, MAHARASHTRA, India

PDEAs collage of ayurved and research centre

🇮🇳Pune, MAHARASHTRA, India

Dr Neeta Hake

Principal investigator

9623117655

neetanashik@gmail.com